May 13, 2020
Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027
May 12, 2020
Novel CAR NK-cell technology could lead to new treatments for lupus, other incurable diseases
Apr 25, 2020
Advisory - Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician
Apr 21, 2020
Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE) Study
Apr 20, 2020
COVID-19 Update - Hydroxychloroquine Market was Estimated to be US$ 41.3 Mn in 2018 and is Growing at a CAGR of 10.4% Over the Forecast Period, Owing to Increasing Demand for Medications to Treat Autoimmune Diseases, Says Absolute Markets Insights
Apr 15, 2020
FDA Grants Fast Track Designation to RemeGen's Telitacicept as a Treatment for Systemic Lupus Erythematosus
Apr 14, 2020
Research Among People Living With Lupus Finds Widespread, Under-Addressed Anxiety and Depression
Apr 09, 2020
Hydroxychloroquine, Lupus and COVID-19: What We've Learned and What's Next?
Apr 08, 2020
65 Percent of Physicians in New Survey Would Give Anti-Malaria Drugs to Their Own Family to Treat COVID-19
Apr 07, 2020
Lupus Therapeutics, Affiliate Of Lupus Research Alliance, Developing A Study Focused On Lupus Patients And COVID-19
Apr 01, 2020
Global Systemic Lupus Erythematosus Report, 10-Year Forecasts, 7MM Coverage and Detailed Pipeline Product Profiles
Mar 26, 2020
Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19
Mar 26, 2020
March 26 Statement: Lupus Research Alliance Puts Plaquenil Shortage Into Perspective For Lupus Community
Mar 12, 2020
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Mar 04, 2020
Mallinckrodt Announces Publication of New Data on Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Dermatomyositis/Polymyositis Published in Open Access Rheumatology: Research and Reviews
Jan 17, 2020
AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco
Jan 08, 2020
Progentec Raises $5M in Series A Funding Led by Plains Venture Partners
Dec 19, 2019
Greater Flexibility in Clinical Trial Design Needed for Lupus
Dec 18, 2019
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
Dec 18, 2019
GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis